Sign inJoin waitlistJoin the waitlist

Premal Lulla

Associate Professor of Medicine · Baylor College of Medicine

Credentials: · · ·

History

Baylor College of Medicine
Present

Baylor College of Medicine
Until 2015
Baylor College of Medicine
Until 2012
D.Y. Patil Medical College & MUHS
2008

Research

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell…
Journal of Clinical Oncology · 2017 · 386 citations
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Journal of Clinical Oncology · 2020 · 318 citations
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
Nature · 2025 · 225 citations

Helen Heslop
25 papers
Carlos Ramos
21 papers
Malcolm Brenner
17 papers
LaQuisa Hill
16 papers · 1 as a fellow
George Carrum
10 papers
RK
Rammurti Kamble
8 papers
Caridad Martinez
7 papers
Rayne Rouce
7 papers
Bilal Omer
6 papers
Stephen Gottschalk
6 papers
Swati Naik
6 papers
Andras Heczey
4 papers

Clinical trials

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)
Principal investigator · Not yet recruiting · Phase 1
The Methodist Hospital Research Institute
2027–2044
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
2025–2043
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
2025–2043
Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas
Principal investigator · Withdrawn · Phase 1
Baylor College of Medicine
2024–2040